Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis
- PMID: 22427859
- PMCID: PMC3302779
- DOI: 10.1371/journal.pone.0032652
Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis
Abstract
Background: The diagnosis of tuberculosis remains difficult. This study aimed to assess performance of interferon-gamma release assay (IGRA) in diagnosis of active tuberculosis (ATB) with pulmonary and extrapulmonary involvements, and to determine the diagnostic role of IGRA (T-SPOT.TB) and tuberculin skin test (TST) in BCG-vaccinated population.
Methods and findings: Two hundred twenty-six ATB suspects were recruited and examined with T-SPOT.TB. Among them, fifty-two and seventy-six subjects were simultaneously tested by TST with 5TU or 1TU of purified protein derivative (PPD). The sensitivity of T-SPOT.TB was 94.7% (71/75), comparable in pulmonary and extrapulmonary disease groups (95.6% vs. 93.3%, P>0.05), while the specificity was 84.10% (90/107) but differed in two groups (69.2% vs. 88.9%, P = 0.02). Compared to T-SPOT.TB, TST with 5TU-PPD showed less sensitivity (92.3% vs. 56.4%) and specificity (84.6% vs. 61.5%) (both P<0.01); the sensitivity of TST with 1TU-PPD was 27.8%, and despite its specificity identical to T-SPOT.TB (both 82.8%) positive predictive value (PPV) was only 33.3%. By combining T-SPOT.TB with TST (1TU), the specificity rose to 95%, but the PPV stayed unchanged.
Conclusions: IGRA could function as a powerful immunodiagnostic test to explore pulmonary and extrapulmonary TB, while TST failed to play a reliable or auxiliary role in identifying TB disease and infection in the BCG-vaccinated population.
Conflict of interest statement
Figures


References
-
- Siu GK, Zhang Y, Lau TC, Lau RW, Ho PL, et al. Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother. 2011;66:730–733. - PubMed
-
- Brodie D, Schluger NW. The diagnosis of tuberculosis. Clin Chest Med. 2005;26:247–271, vi. - PubMed
-
- Cohn DL, O'Brien RJ, Geiter LJ, Gordin FM, Hershfield E, et al. Supplement - American Thoracic Society Centers for Disease Control and Prevention - Targeted tuberculin testing and treatment of latent tuberculosis infection. American Journal of Respiratory and Critical Care Medicine. 2000;161:S221–S247. - PubMed
-
- Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med. 2006;174:736–742. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical